The United States included $4 billion for Gavi in its latest COVID-19 relief package.

True if the most recent US COVID-19 relief law enacted as of February 2021 (the Consolidated Appropriations Act, 2021, signed December 2020) appropriated about $4 billion for Gavi (including funding for COVAX through Gavi). Mostly true if the amount was about $4 billion for Gavi/COVAX but with a minor difference in how it was described (e.g. routed through USAID for Gavi), or if the figure was roughly but not exactly $4 billion (within about 10%). Mostly false if the funding was a much smaller or different amount, or was in a bill that had not been enacted. False if no relief package included funding for Gavi.

Set before the research began.

1. E1 USAID Should Consider Enhancing Oversight to Mitigate Risk of Fraud, Waste, and Abuse (U.S. COVID-19 Vaccine Contributions, Report E-000-21-002-M) USAID Office of Inspector General · 1 September 2021

   “In December 2020, the U.S. Congress appropriated $4 billion for international COVID-19 vaccine procurement and delivery through a contribution to Gavi.”

2. E2 USAID Should Consider Enhancing Oversight to Mitigate Risk of Fraud, Waste, and Abuse (U.S. COVID-19 Vaccine Contributions, Report E-000-21-002-M) USAID Office of Inspector General · 1 September 2021

   “The FY 2021 Omnibus and COVID Relief and Response Act H.R. 133. Congressional appropriations language directed the funds be issued as a contribution”

3. E3 USAID Should Consider Enhancing Oversight to Mitigate Risk of Fraud, Waste, and Abuse (U.S. COVID-19 Vaccine Contributions, Report E-000-21-002-M) USAID Office of Inspector General · 1 September 2021

   “USAID contributed $2 billion to Gavi for the procurement and distribution of COVID-19 vaccines through COVAX on March 8, 2021, with another $2 billion to be provided by September 2022.”

The USAID Office of Inspector General report says Congress appropriated $4 billion in December 2020 for international COVID-19 vaccine procurement and delivery through a contribution to Gavi (E1). The same report names the law as H.R. 133, the FY 2021 Omnibus and COVID Relief and Response Act, which is the Consolidated Appropriations Act, 2021 (E2). It also records that USAID paid the first $2 billion of that money to Gavi for COVAX in March 2021 (E3). This matches the claim under the criteria.